Topics

Companies Related to "Sanofi dengue vaccine wins limited approval" [Most Relevant Company Matches] - Page: 4 RSS

06:53 EST 12th November 2019 | BioPortfolio

Here are the most relevant search results for "Sanofi dengue vaccine wins limited approval" found in our extensive corporate database of over 50,000 company records.

Showing "Sanofi dengue vaccine wins limited approval" Companies 76–100 of 777

Relevant

Genzyme, a Sanofi Company

Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals through world-class research and with the compassion and commitment of our employees. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive im...


Bio-Bridge Science

Bio-Bridge Science, Inc., a development stage biotechnology company, engages in the commercial development of vaccines for the prevention and treatment of human infectious diseases. The company is currently developing and commercializing HIV-PV Vaccine I to prevent and treat infection by the human immunodeficiency virus (HIV). It develops HIV vaccines for both preventive and therapeutic purposes. ...

Probably Relevant

Pebble Labs Inc.

Founded at the New Mexico Consortium, Pebble Labs Inc. is a biotechnology company developing biologically engineered bacteria to eliminate the transmission of mosquito-carried viruses including Zika and Dengue and other viral- and fungal-based diseases in crops and aquaculture. www.pebblelabs.com


sanofi pasteur and The March of Dimes

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

Whole Health Management

Whole Health is the leader in quality and service for the on-site health care industry. From primary and urgent care to preventative health and wellness programs, we’ve cared for over 5 million patients in the last two decades – all while reducing costs and increasing employee productivity2005Whole Health has more than 500 associates working at on-site health and fitness centers for 29 client ...

Themis

Themis is developing urgently needed vaccines to prevent death and disability around the world. We lead in the development of a vaccine against chikungunya, a serious debilitating disease with global outbreak potential. Our innovation in vaccine technology has created a powerful platform and a growing pipeline addressing a broad range of infectious disease...

BioSante Pharmaceuticals, Inc.

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante’s lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol...

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of VPCL has an accumulated experience in various areas of Bulk Drug industry such as Research and Development (R& D), Production, Designing, and Fabrication of Equipment,Quality Control, materials and Mar...

sanofi pasteur S.A.

It is rare for a company's history to be so tightly interwoven with the history of a major health care discovery. Sanofi pasteur is the result of the meeting of three exceptional destinies, those of men who left their mark on the history of vaccination: Louis Pasteur, the Mérieux family and John FitzGerald. These three destinies very likely converged because they were all moving in the same direc...

Mucosis

Mucosis B.V. is a clinical-stage biotechnology company developing novel vaccines on its proprietary Mimopath® platform technology. The Mimopath® platform is being studied for various routes of administration including those that provide additional protection in the mucosa, the site where over 90% of pathogens enter the human body. Mucosis’s lead...

AARTI INDUSTRIES LIMITED

The first unit of AARTI group, ALCHEMIE LABORATORIES, commenced commercial production of DIMETHYL SULPHATE (DMS) in the year 1975. Today, AARTI has acquired world-class expertise in the development and manufacturing of basic bulk chemicals, dyes & pigment intermediates, pharmaceuticals & agrochemicals along with their intermediates, rubber chemicals, surfactant intermediates and speciality chemica...

Pure Protein, L.L.C.

Pure Protein is an HLA Center of Excellence - developing immunology tools for therapeutic and diagnostic applications in solid organ and stem cell transplantation, cross-reactive antibody screening, and major autoimmune diseases. Pure Protein was formed in 1999 to commercialize research developed at the University of Oklahoma Health Sciences Center. Pure T...

Themis Bioscience

Themis is developing urgently needed vaccines to prevent death and disability around the world. We lead in the development of a vaccine against chikungunya, a serious debilitating disease with global outbreak potential. Our innovation in vaccine and immune activation technology has created a powerful platform and a growing pipeline addressing a broad range...

VaxInnate Corporation

VaxInnate is a privately-held biotechnology company in Cranbury, NJ that is pioneering breakthrough technology for use in developing novel and proprietary vaccines. VaxInnate’s proprietary technology -- based upon a combination of toll-like receptor-mediated (TLR) immune enhancement and recombinant bacterial production of vaccine antigen -- conveys si...

PaxVax Inc.

PaxVax is a privately held specialty vaccine company founded in 2007. PaxVax is focused on traveler vaccines with an emerging pipeline in biodefense coupled with a social mission to ensure global access to its vaccines. PaxVax’s clinical-stage product portfolio includes an oral, single-dose cholera vaccine in Phase 3 clinical trials, a pandemic H5N1 i...

Avantogen Oncology

Avantogen Limited is a drug development Company whose current activities are focused on its three product candidates, namely, RP101 (a potential therapy for pancreatic cancer), GPI-0100 (vaccine adjuvants) and Pentrys™ (cancer vaccine). The Company is currently overseeing Phase II human testing of RP101 in Germany, Phase I human testing of GPI-0100 in the U.S and Phase II human testing of the P...

GENFIT

GENFIT (Paris:ALGFT) is a biopharmaceutical company focused on the Discovery and Development of drug candidates in strategic therapeutic fields linked to cardiometabolic and neurodegenerative disorders (prediabetes/diabetes, atherosclerosis, dyslipidemia, obesity, Alzheimer’s…). GENFIT uses a multi-pronged approach based on early diagnosis, preve...

Southern Research Institute

65 Years of Southern ResearchThe year is 1941.In the United States, ten television stations are granted the first commercial TV licenses, allowing them to begin broadcasting in July. The stations are required to broadcast 15 hours per week. Station WNBT in New York signs the Bulova Watch Co., Sun Oil Co., Lever Bros. Co. and Procter & Gamble as sponsors of the station's first commercial telecasts....

International Medica Foundation

The International Medica Foundation, which has the rights to RotaShield, is a nonprofit foundation that focuses on ensuring that a safe, effective and affordable rotavirus vaccine is clinically tested and then can be provided to families in need globally. The International Medica Foundation also aims to ensure that the manufacturing process for Rota...

Medafor Inc.

Medafor is a privately held Minnesota Corporation based in Minneapolis. Medafor was founded to develop applications and markets for its patented, plant-based, flowable hemostatic powder technology. MPH(r) is a microporous, polysaccharide hemostatic agent that is engineered to rapidly dehydrate blood and accelerate clotting. Medafor received FDA approval fo...

AVAX Technologies, Inc.

AVAX Technologies, Inc. is a biotechnology company with operations in the United States and Europe. The Company is engaged in the research, clinical and commercial development of biological products and cancer therapeutics. AVAX’s AC Vaccine platform is a therapeutic cancer vaccine. In addition, the Company performs contract-manufacturing services for...

Curevo, Inc.

Curevo is working to provide excellence in protein science and adjuvant technology to speed safe and highly effective vaccines from the bench through clinical development. Curevo will focus on vaccine-preventable illnesses that are common in both the Asian and US markets. Curevo’s goal is to rapidly advance innovative new vaccine candidates from research laboratory to clinic by joining force...

Samarind Limited

Samarind Limited, based five miles outside the historic city of Chester, was founded in 1987 and has grown steadily to become one of the leading life sciences software houses in the UK. Originally a bespoke software house, Samarind developed the first version of its flagship product Samarind RMS in 2003. Since then it has undergone a number of major upgrades and now stands at version 4. In 200...

Polynoma, Inc.

Polynoma, Inc. is an oncology-focused biotechnology company based in San Diego, the United States of America. Polynoma’s lead product candidate is the therapeutic vaccine POL 103A for the treatment of melanoma. The Phase 3 trial of POL 103A was initiated based on two randomized, controlled Phase 2 trials that showed statistically significant efficacy ...

Accelerator Corp

VieVax Corp. is focused on commercializing a novel approach to vaccine development that is designed to overcome the limitations of existing vaccine technologies. These technologies, largely unchanged and unimproved for the past half-century, have consistently fallen short in addressing a number of critical issues, including: the spread of serious emerging infectious diseases, the emergence of trea...


More From BioPortfolio on "Sanofi dengue vaccine wins limited approval"

Quick Search

Corporate Database Quicklinks